ANALYSIS: With an Obermatt 360° View of 84 (better than 84% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Quest Diagnostics are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Quest Diagnostics. The consolidated Value Rank has an attractive rank of 65, which means that the share price of Quest Diagnostics is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 65% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 51, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 99. But the company’s financing is risky with a Safety rank of 49. This means 51% of comparable companies have a safer financing structure than Quest Diagnostics. ...read more